Atlas Trials

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Clinical trial NCT01266707 · UNKNOWN

Trial details

NCT number
NCT01266707
Sponsor
Fukushima Medical University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2007-03-01
Primary completion
2012-03-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.